Neurocrine Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	305.8	341.3	249.7	154.5	89.6	407.3	Upgrade
Depreciation & Amortization	28.5	27.1	21.3	15.6	10.9	8.6	Upgrade
Other Amortization	-88.7	-	-	-	17.3	21.4	Upgrade
Loss (Gain) From Sale of Investments	45.6	10.9	-46.7	-27.1	-13.5	17.7	Upgrade
Stock-Based Compensation	203.8	195.5	194.3	173.1	134.2	100	Upgrade
Other Operating Activities	46.2	39.8	-56.9	90.7	1.3	-288.6	Upgrade
Change in Accounts Receivable	-65.4	-39.8	-89.3	-162.2	-28.4	-30.5	Upgrade
Change in Inventory	-21.9	-19.1	5.4	-2.6	-2.5	-10.7	Upgrade
Change in Accounts Payable	60	29	64.3	114.6	56.8	26.9	Upgrade
Change in Other Net Operating Assets	16	10.7	47.8	-17.2	-9.2	-23.6	Upgrade
Operating Cash Flow	529.9	595.4	389.9	339.4	256.5	228.5	Upgrade
Operating Cash Flow Growth	-17.90%	52.71%	14.88%	32.32%	12.25%	55.44%	Upgrade
Capital Expenditures	-37.7	-38.2	-28.3	-16.5	-23.4	-10.9	Upgrade
Cash Acquisitions	-	-	-	-42.7	-	-	Upgrade
Investment in Securities	-19.9	-88.6	-438.8	-117.9	-106.8	15	Upgrade
Investing Cash Flow	-57.6	-126.8	-467.1	-177.1	-130.2	4.1	Upgrade
Long-Term Debt Repaid	-	-308.8	-	-279	-0.1	-186.9	Upgrade
Net Debt Issued (Repaid)	-308.8	-308.8	-	-279	-0.1	-186.9	Upgrade
Issuance of Common Stock	84.3	122.1	65.3	44.7	27.5	29.1	Upgrade
Repurchase of Common Stock	-450	-300	-	-	-	-	Upgrade
Financing Cash Flow	-674.5	-486.7	65.3	-234.3	27.4	-157.8	Upgrade
Foreign Exchange Rate Adjustments	-	-	0.3	-1.3	-	-	Upgrade
Net Cash Flow	-202.2	-18.1	-11.6	-73.3	153.7	74.8	Upgrade
Free Cash Flow	492.2	557.2	361.6	322.9	233.1	217.6	Upgrade
Free Cash Flow Growth	-19.89%	54.09%	11.98%	38.52%	7.12%	64.48%	Upgrade
Free Cash Flow Margin	20.40%	23.66%	19.16%	21.69%	20.57%	20.80%	Upgrade
Free Cash Flow Per Share	4.76	5.37	3.58	3.27	2.38	2.23	Upgrade
Cash Interest Paid	1.6	1.6	3.8	6.6	8.6	11.6	Upgrade
Cash Income Tax Paid	217.9	217.5	51.5	14.4	5.1	15.3	Upgrade
Levered Free Cash Flow	235.48	457.98	439.25	247.63	265.75	278.59	Upgrade
Unlevered Free Cash Flow	324.18	457.98	439.25	247.63	264.58	277.69	Upgrade
Change in Net Working Capital	183.8	90.8	-5.2	80.2	-13	24.7	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.